1. Association between echocardiographic features and inflammatory biomarkers with clinical outcomes in COVID-19 patients in Saudi Arabia
- Author
-
Samah I. Abohamr, Rami M. Abazid, Mohammed K. Alhumaid, Abubaker E. Abdulrahim, Mubarak A. Aldossari, Lamiaa Khedr, Rehab H. Werida, Haifa S. Alkheledan, Yazeed S. Aleid, Sara W. Abdelhamid, Abdulmohsen Al Mefarrej, Ahmed W. Abdelhamid, Mohammad Hasan Alaboud, Omar T. Alhasan, Hanem M. Gomaa, and Eman Elsheikh
- Subjects
echocardiography ,COVID-19 ,outcome ,biomarker ,thrombus ,mortality ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundRespiratory infections are one of the most common comorbidities identified in hospitalized patients. The coronavirus disease 2019 (COVID-19) pandemic greatly impacted healthcare systems, including acute cardiac services.AimThis study aimed to describe the echocardiographic findings of patients with COVID-19 infections and their correlations with inflammatory biomarkers, disease severity, and clinical outcomes.MethodsThis observational study was conducted between June 2021 and July 2022. The analysis included all patients diagnosed with COVID-19 who had transthoracic echocardiographic (TTE) scans within 72 h of admission.ResultsThe enrolled patients had a mean age of 55.6 ± 14.7 years, and 66.1% were male. Of the 490 enrolled patients, 203 (41.4%) were admitted to the intensive care unit (ICU). Pre-ICU TTE findings showed significantly higher incidence right ventricular dysfunction (28 [13.8%] vs. 23 [8.0%]; P = 0.04) and left ventricular (LV) regional wall motion abnormalities (55 [27.1%] vs. 29 [10.1%]; p
- Published
- 2023
- Full Text
- View/download PDF